Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+4.50%
-3.98%
+0.20%
-0.73%
+9.23%
BNTX
BioNTech
$98.10
Login to display BioNTech (BNTX) recommendation from the last 90 days from financial news and social media. Chart
$100.42 (-2.31%)
$111.66 (-12.14%)
$94.78 (+3.50%)
$120.14 (-18.35%)
BNTX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
BNTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Revenue increase YoY
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
BNTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BNTX Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayBNTX Earnings
The TTM reflects 12-month period, providing review of BNTX financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is BNTX current stock price?
What are BNTX stock strengths?
What risks are associated with BNTX stock?
When is BNTX next earnings report?
What is BNTX market cap and volume?
What is BNTX's current Stock IQ?
Should I buy BNTX stock right now?
Is BNTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BNTX?
What does a 'Strong Sell' rating mean for BNTX?
What factors influence BNTX's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.50%
-3.98%
+0.20%
-0.73%
+9.23%
BNTX
BioNTech
Current Price
$98.10
Stock Insights
Not Enough Information
Login to view BioNTech (BNTX) recommendation from the last 90 days from financial news and social media.
Chart
$100.42 (-2.31%)
$111.66 (-12.14%)
$94.78 (+3.50%)
$120.14 (-18.35%)
BNTX Analysts Opinion
BNTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Revenue increase YoY
Rating
Rating
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
BNTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BNTX Street view is bullish and have positive views on the near-term outlook
BNTX has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
Login to displayBNTX Earnings
The TTM data reflects the most recent 12-month period, providing overview of BNTX financial performance.
BNTX Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
BNTX Latest Analysis
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises. MarketNewsUpdates News Commentary from BioSpace the global size was Avant Technologies Inc. (OTCQB:) Tempus AI Inc. (NASDAQ:) CRISPR Therapeutics (NASDAQ:) BioNTech SE (NASDAQ:) Bristol Myers Squibb Company (NYSE:). The report said: ".Major Trends in the Cell Therapy Market Are: Demand for Regenerative Medicine: Patients with untreated illnesses and due to its ability to restore the f
Thu Sep 18, 2025
Pfizer Moderna BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths. Shares of COVID-19 vaccine makers ) ) and ) are trading lower Friday following a report that Trump administration health officials intend to link the vaccines to 25 child deaths. This assertion is reportedly based on unverified submissions to the Vaccine Adverse Event Reporting System.Per the Washington Post this panel the Advisory Committee on Immunization Practices is considering new more restric
Fri Sep 12, 2025
BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?. Bristol Myers and BioNTech report strong mid-stage lung cancer trial data for pumitamig showing high response rates and manageable safety.
Fri Sep 12, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
BNTX Stock trends
BNTX Stock performance
BNTX Stock analysis
BNTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings